Bevacizumab-containing Chemotherapy is Safe in Patients with Unresectable Metastatic Colorectal Cancer and a Synchronous Asymptomatic Primary Tumor


Cetin B., Kaplan M. A. , Berk V., Tufan G., Benekli M., Isikdogan A., ...Daha Fazla

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, cilt.43, ss.28-32, 2013 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 43 Konu: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1093/jjco/hys175
  • Dergi Adı: JAPANESE JOURNAL OF CLINICAL ONCOLOGY
  • Sayfa Sayıları: ss.28-32

Özet

Surgical resection of asymptomatic primary colorectal cancer in patients presenting with synchronous unresectable metastatic disease is controversial. Concerns and controversies remain over combining cytotoxic chemotherapy with bevacizumab in this patient population.